More recently, Rath et al. [42] demonstrated that fascaplysin exerts an anti-proliferative and pro-apoptotic effect in lung cancer and small-cell lung cancer circulating tumour cell lines by involving AKT/PKB and adenosine monophosphate-activated protein kinase (AMPK) pathways. This evidence concerns the gene AKT1 and lung carcinoma.